Bulletin
Investor Alert

AmerisourceBergen Corp.

NYS: ABC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jun 5, 2020, 5:38 p.m.

ABC
/zigman2/quotes/201066379/composite

$

98.90

Change

-0.07 -0.07%

Volume

Volume 37,114

Quotes are delayed by 20 min

/zigman2/quotes/201066379/composite

Previous close

$ 99.45

$ 98.97

Change

-0.48 -0.48%

Day low

Day high

$98.51

$102.21

Open

52 week low

52 week high

$72.06

$102.21

Open

Kathy Habecker Gaddes

Presently, Kathy Habecker Gaddes is Chief Compliance Officer & Executive Officer at AmerisourceBergen Corp.

In her past career she occupied the position of Principal at Dechert LLP and Associate Corporate Secretary at ARCO Chemical Co.

Ms. Gaddes received an undergraduate degree from Franklin & Marshall College and a graduate degree from The University of Pennsylvania Law School.

Transactions

Date Shares Transaction Value
02/21/2020 22,140   Disposition at $96.84 per share. 2,144,038
02/21/2020 22,140   Derivative/Non-derivative trans. at $75.61 per share. 1,674,005
02/05/2020 8,690   Disposition at $91.44 per share. 794,614
02/05/2020 8,690   Derivative/Non-derivative trans. at $68.49 per share. 595,178
12/31/2019 30   Award at $72.27 per share. 2,168
11/14/2019 333   Derivative/Non-derivative trans. at $82.33 per share. 27,416
11/14/2019 1,169   Award at $0 per share. 0
11/08/2019 754   Derivative/Non-derivative trans. at $86.07 per share. 64,897
11/08/2019 2,645   Derivative/Non-derivative trans. at $0 per share. 0
06/28/2019 27   Award at $72.47 per share. 1,956
05/17/2019 851   Derivative/Non-derivative trans. at $77.73 per share. 66,149
05/17/2019 3,000   Derivative/Non-derivative trans. at $0 per share. 0
12/31/2018 34   Award at $63.24 per share. 2,150
11/20/2018 2,652   Disposition at $90.54 per share. 240,113
11/20/2018 2,652   Derivative/Non-derivative trans. at $40.21 per share. 106,636
11/09/2018 280   Derivative/Non-derivative trans. at $88.86 per share. 24,881
11/09/2018 980   Derivative/Non-derivative trans. at $88.86 per share. 87,082
10/22/2018 2,652   Disposition at $92.96 per share. 246,530
10/22/2018 2,652   Derivative/Non-derivative trans. at $40.21 per share. 106,636
09/20/2018 2,652   Disposition at $89.79 per share. 238,124
09/20/2018 2,652   Derivative/Non-derivative trans. at $40.21 per share. 106,636
08/20/2018 2,652   Disposition at $87.71 per share. 232,607
08/20/2018 2,652   Derivative/Non-derivative trans. at $40.21 per share. 106,636
07/20/2018 2,028   Disposition at $85 per share. 172,380
07/20/2018 2,028   Derivative/Non-derivative trans. at $40.21 per share. 81,545
07/20/2018 624   Disposition at $85 per share. 53,040
07/20/2018 624   Derivative/Non-derivative trans. at $37.37 per share. 23,318
06/20/2018 2,652   Disposition at $92.03 per share. 244,064
06/20/2018 2,652   Derivative/Non-derivative trans. at $37.37 per share. 99,105
11/10/2017 212   Derivative/Non-derivative trans. at $75 per share. 15,900
11/10/2017 671   Derivative/Non-derivative trans. at $0 per share. 0
11/11/2016 242   Derivative/Non-derivative trans. at $78.92 per share. 19,099
09/07/2016 681   Disposition at $88.15 per share. 60,031

Officers and Executives

Mr. Steven H. Collis
Chairman, President & Chief Executive Officer
Mr. James Francis Cleary
Chief Financial Officer & Executive Vice President
Mr. Dale B. Danilewitz
Chief Information Officer & Executive VP
Ms. Gina K. Clark
Chief Communications & Administration Officer, EVP
Ms. Leslie E. Donato
Chief Strategy Officer & Executive Vice President
Mr. Rafael Augusto Kosa Teixeira
Senior Vice President-Transformation
Ms. Kathy Habecker Gaddes
Chief Compliance Officer & Executive Officer
Mr. Sun Park
Executive Vice President
Dr. Robert P. Mauch
EVP & Group President-Pharmaceutical Distribution
Ms. Ornella Barra
Non-Independent Director
Mr. Jack F. Quinn
Treasurer & Vice President
Mr. Lazarus Krikorian
Principal Accounting Officer, SVP & Controller
Mr. Bennett S. Murphy
Vice President-Investor Relations
Ms. Silvana Battaglia
Chief Human Resources Officer & Executive VP
Mr. John G. Chou
Executive VP, Chief Legal Officer & Secretary
Mr. Dennis M. Nally
Independent Director
Mr. Henry Wadsworth McGee
Independent Director
Mr. Richard W. Gochnauer
Independent Director
Dr. Jane Ellen Henney
Lead Independent Director
Ms. Kathleen W. Hyle
Independent Director
Mr. Michael J. Long
Independent Director
Mr. Lon R. Greenberg
Independent Director
Mr. D. Mark Durcan
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.